Novel association of NAV3 with dilated cardiomyopathy and its role in cardiac fibrosis.
Saved in:
| Title: | Novel association of NAV3 with dilated cardiomyopathy and its role in cardiac fibrosis. |
|---|---|
| Authors: | Wang M; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States., Ghazal R; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States., Srinivas AN; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States., Nguyen TTL; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States., Murthy V; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States., McNamara DM; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States., Skime MK; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, United States., Batzler A; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States., Jenkins GD; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States., Barlera S; Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Pileggi S; Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Mestroni L; Division of Cardiology, Cardiovascular Institute, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States., Merlo M; Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy., Pinet F; Inserm U1167, Institut Pasteur de Lille, Université de Lille, Lille, France., Krejčí J; First Internal Clinic of Cardio-Angiology, St. Anne's University Hospital and Medical School of Masaryk University, Brno, Czech Republic., Chaloupka A; First Internal Clinic of Cardio-Angiology, St. Anne's University Hospital and Medical School of Masaryk University, Brno, Czech Republic., de Groote P; Inserm U1167, Institut Pasteur de Lille, Université de Lille, Lille, France.; Service de cardiologie, Pôle cardiovasculaire et Pulmonaire, CHRU de Lille, Lille, France., Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States., Tschumperlin DJ; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, United States., Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States., Pereira NL; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States. |
| Source: | American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2026 Mar 01; Vol. 330 (3), pp. H686-H696. Date of Electronic Publication: 2026 Jan 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1539 (Electronic) Linking ISSN: 03636135 NLM ISO Abbreviation: Am J Physiol Heart Circ Physiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1522-1539 |
|---|---|
| DOI: | 10.1152/ajpheart.00806.2025 |
